Fatma U Afifi1, Mayyada Wazaify, Mohammad Jabr, Emad Treish. 1. Department of Pharmaceutical Sciences, Faculty of Pharmacy, The University of Jordan Queen Rania Al-Abdallah Street, Amman 11942, Jordan. fatueafi@ju.edu.jo
Abstract
PURPOSE: This study sought to describe the type, frequency, purpose and pattern of herbal preparation use as complementary medicine in a sample of patients with cancer in Jordan. METHOD: The study took the form of a cross-sectional survey of patients attending the outpatient departments at King Hussein Cancer Centre (KHCC), a specialist cancer centre in Amman. The method was based on using a semi-structured questionnaire. RESULTS: A total of 1138 patients with cancer were interviewed, out of which 404 (35.5%) reported using botanicals based complementary and alternative medicine (CAM) primarily bought form Jordan (85.1%) and used in the crude form as infusions (73.3%). Only 6.8% used herbal products in a dosage form. Most of CAM users were above 40 years of age (63.1%). Recommendation of a friend was the main factor that prompted them to use CAM (41.8%). CONCLUSION: This study revealed that CAM use is common among patients with cancer in Jordan.
PURPOSE: This study sought to describe the type, frequency, purpose and pattern of herbal preparation use as complementary medicine in a sample of patients with cancer in Jordan. METHOD: The study took the form of a cross-sectional survey of patients attending the outpatient departments at King Hussein Cancer Centre (KHCC), a specialist cancer centre in Amman. The method was based on using a semi-structured questionnaire. RESULTS: A total of 1138 patients with cancer were interviewed, out of which 404 (35.5%) reported using botanicals based complementary and alternative medicine (CAM) primarily bought form Jordan (85.1%) and used in the crude form as infusions (73.3%). Only 6.8% used herbal products in a dosage form. Most of CAM users were above 40 years of age (63.1%). Recommendation of a friend was the main factor that prompted them to use CAM (41.8%). CONCLUSION: This study revealed that CAM use is common among patients with cancer in Jordan.
Authors: Eran Ben-Arye; Elad Schiff; Kamer Mutafoglu; Suha Omran; Ramzi Hajjar; Haris Charalambous; Tahani Dweikat; Ibtisam Ghrayeb; Gil Bar Sela; Ibrahim Turker; Azza Hassan; Esmat Hassan; Ariela Popper-Giveon; Bashar Saad; Omar Nimri; Rejin Kebudi; Jamal Dagash; Michael Silbermann Journal: Support Care Cancer Date: 2015-01-24 Impact factor: 3.603
Authors: Eran Ben-Arye; Mohammed Saleem Ali-Shtayeh; Mati Nejmi; Elad Schiff; Esmat Hassan; Kamer Mutafoglu; Fatma U Afifi; Rana Majed Jamous; Efraim Lev; Michael Silbermman Journal: Support Care Cancer Date: 2011-03-01 Impact factor: 3.603
Authors: Jennifer E Rosen; Paula Gardiner; Robert B Saper; Amanda C Filippelli; Laura F White; Elizabeth N Pearce; Rebecca L Gupta-Lawrence; Stephanie L Lee Journal: Thyroid Date: 2013-07-25 Impact factor: 6.568
Authors: Darren Hunter; Christopher Marinakis; Ruth Salisbury; Alison Cray; Richard Oates Journal: Support Care Cancer Date: 2015-10-08 Impact factor: 3.603
Authors: John Baptist Asiimwe; Prakash B Nagendrappa; Esther C Atukunda; Mauda M Kamatenesi; Grace Nambozi; Casim U Tolo; Patrick E Ogwang; Ahmed M Sarki Journal: Evid Based Complement Alternat Med Date: 2021-05-17 Impact factor: 2.650